Restorative Surgery That Patients Can Smile About
Joshua D. Rosenberg, MD, Assistant Professor of Otolaryngology at Icahn School of Medicine at Mount Sinai, is one of only a handful of U.S. surgeons who is using an innovative new procedure to restore the ability to smile in patients with facial paralysis. The...
Repurposing a Drug to Prevent and Treat Cancers
Two studies published recently in the Proceedings of the National Academy of Sciences, led by researchers at the Icahn School of Medicine at Mount Sinai, demonstrate how widely used, inexpensive medications to treat osteoporosis, known as bisphosphonates, have the...
Forbes Honors Pioneering Neurosurgery Resident
Eric Oermann, MD, a pioneering Neurosurgery second-year resident at Icahn School of Medicine at Mount Sinai, has been named to the fourth annual Forbes “30 Under 30” list as one of the nation’s top Health Care innovators for 2015. According to Forbes, the honorees...
New Discoveries in the Treatment of Eczema
Seminal research led by Emma Guttman-Yassky, MD, Associate Professor of Dermatology, and Medicine (Clinical Immunology), at Icahn School of Medicine at Mount Sinai, has identified the key drivers of eczema and given rise to promising new treatments that appear to...
Researchers Identify Potential Ebola-Fighting Drugs
Researchers at the Icahn School of Medicine at Mount Sinai have identified 53 drugs approved for use in treating depression, cancer, heart disease, and other illnesses that may also be effective in fighting the Ebola virus. The findings appeared online in the December...
A New Era for Bone Marrow Transplantation
Seminal research led by James Ferrara, MD, DSc, Ward-Coleman Chair in Cancer Medicine, has produced a promising approach to treating patients with graft-versus-host disease (GVHD)—a sometimes fatal complication of bone marrow transplantation in which the donor’s...
Attention Statin Patients: Are You Experiencing Muscle Aches, Weakness, Decreased Exercise Capacity, “Brain Fog”, Impaired Clarity, or Memory Loss?
If you are experiencing any of these symptoms, you may have statin intolerance. What are statins? Statins are a class of cholesterol lowering medication therapies that have been extensively evaluated in controlled clinical trial studies. These medications have been...
Top Honors for Groundbreaking Researchers
For the first time in its 47-year history, the Crohn’s & Colitis Foundation of America has awarded all three of its 2014 annual scientific achievement awards to research and academic luminaries at the Mount Sinai Health System. “It seems quite fitting that they...
Studying New Stem Cell Therapies for Vision Recovery
The National Eye Institute (NEI), a division of the National Institutes of Health, has awarded researchers at Icahn School of Medicine at Mount Sinai a five-year grant to support an effort to recreate a patient’s ocular stem cells and restore vision in those blinded...